Kim Lavin - Verus LLC - Page 2 of 20

Zantac-related claims for the GSK lawsuit involving mass tort litigation.

GSK Gets a Win in Zantac Case in Illinois Circuit Court; Trial Against Boehringer Ends in a Deadlock

Management and litigation support services enhancing customer experience at Verus LLC.

Client-Centric Strategies in Mass Tort Litigation: Verus’ Expertise

Texas Two-Step strategy in mass tort litigation with expertise in asbestos and product liability cases.

Appeals Court Rejects J&J’s Second “Texas Two-Step” Bankruptcy Attempt

Zantac medication a common subject of mass tort cases.

State Court Zantac Litigation Update

Depicting the severity of the opioid crisis and its consequences.

SCOTUS Decision Jeopardizes $6 Billion Opioid Settlement by Denying Nonconsensual Third-Party Releases for the Sackler Family

Johnson & Johnson talc case for mass tort litigation support.

Status Update on J&J’s Proposed Third Bankruptcy Filing

Verus LLC provides customized solutions for litigation support and analytics.

Innovative Solutions for Mass Tort Litigation: Verus’ End-to-End Support Services

Verus LLC's team collaborating on mass tort litigation support for settlement administration.

The Benefits of Working with a Skilled Settlement Administrator

Screenshot 2024 06 27 091717

Status Update on J&J’s Proposed Third Bankruptcy Filing June 26, 2024

Audits 6.25.24

Ensuring Credibility and Integrity in Mass Tort Claims: The Role of Audits & Compliance